143 related articles for article (PubMed ID: 20968198)
1. Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke.
Bajenaru O; Tiu C; Moessler H; Antochi F; Muresanu D; Popescu BO; Novak P
J Med Life; 2010; 3(2):137-43. PubMed ID: 20968198
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
Ladurner G; Kalvach P; Moessler H;
J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
[No Abstract] [Full Text] [Related]
4. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study.
Stan A; Birle C; Blesneag A; Iancu M
J Med Life; 2017; 10(4):216-222. PubMed ID: 29362596
[No Abstract] [Full Text] [Related]
5. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
Lang W; Stadler CH; Poljakovic Z; Fleet D;
Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
[TBL] [Abstract][Full Text] [Related]
6. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
7. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
Muresanu DF; Heiss WD; Hoemberg V; Bajenaru O; Popescu CD; Vester JC; Rahlfs VW; Doppler E; Meier D; Moessler H; Guekht A
Stroke; 2016 Jan; 47(1):151-9. PubMed ID: 26564102
[TBL] [Abstract][Full Text] [Related]
8. Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage.
Woo PYM; Ho JWK; Ko NMW; Li RPT; Jian L; Chu ACH; Kwan MCL; Chan Y; Wong AKS; Wong HT; Chan KY; Kwok JCK
BMC Neurol; 2020 Nov; 20(1):401. PubMed ID: 33143640
[TBL] [Abstract][Full Text] [Related]
9. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials.
Zhang D; Dong Y; Li Y; Chen J; Wang J; Hou L
Biomed Res Int; 2017; 2017():4191670. PubMed ID: 28656143
[TBL] [Abstract][Full Text] [Related]
11. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.
Zhang L; Chopp M; Lu M; Zhang T; Winter S; Doppler E; Meier D; Chao L; Eapen A; Pabla P; Gang Zhang Z
Int J Stroke; 2016 Apr; 11(3):347-55. PubMed ID: 26763925
[TBL] [Abstract][Full Text] [Related]
12. Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke.
Chang WH; Park CH; Kim DY; Shin YI; Ko MH; Lee A; Jang SY; Kim YH
BMC Neurol; 2016 Mar; 16():31. PubMed ID: 26934986
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials.
Guekht A; Vester J; Heiss WD; Gusev E; Hoemberg V; Rahlfs VW; Bajenaru O; Popescu BO; Doppler E; Winter S; Moessler H; Muresanu D
Neurol Sci; 2017 Oct; 38(10):1761-1769. PubMed ID: 28707130
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation.
Martinez RM
J Med Life; 2017; 10(3):161-166. PubMed ID: 29075344
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials.
Bornstein NM; Guekht A; Vester J; Heiss WD; Gusev E; Hömberg V; Rahlfs VW; Bajenaru O; Popescu BO; Muresanu D
Neurol Sci; 2018 Apr; 39(4):629-640. PubMed ID: 29248999
[TBL] [Abstract][Full Text] [Related]
16. [The effect of cerebrolysin in dosage 50 ml on the volume of lesion in ischemic stroke].
Shamalov NA; Stakhovskaia LV; Burenchev DV; Kichuk IV; Tvorogova TV; Botsina AIu; Smychkov AS; Kerbikov OB; Moessler H; Novak P; Skvortsova VI
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):34-7. PubMed ID: 21626816
[TBL] [Abstract][Full Text] [Related]
17. Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke.
Zhang L; Chopp M; Wang C; Zhang Y; Lu M; Zhang T; Zhang ZG
J Neurol Sci; 2019 Mar; 398():22-26. PubMed ID: 30665068
[TBL] [Abstract][Full Text] [Related]
18. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
Guekht AB; Moessler H; Novak PH; Gusev EI;
J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.
Alvarez XA; Cacabelos R; Sampedro C; Aleixandre M; Linares C; Granizo E; Doppler E; Moessler H
Eur J Neurol; 2011 Jan; 18(1):59-68. PubMed ID: 20500802
[TBL] [Abstract][Full Text] [Related]
20. [Results of the multicenter prospective study of cerebrolysin safety and efficacy in acute stroke].
Skwortsova VI; Stakhovskaia LV; Shamalov NA; Kerbikov OB
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():41-5. PubMed ID: 18196634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
